Inna L. Karpenko

791 total citations
43 papers, 607 citations indexed

About

Inna L. Karpenko is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Inna L. Karpenko has authored 43 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 21 papers in Molecular Biology and 17 papers in Epidemiology. Recurrent topics in Inna L. Karpenko's work include HIV/AIDS drug development and treatment (20 papers), Biochemical and Molecular Research (14 papers) and Synthesis and Characterization of Heterocyclic Compounds (6 papers). Inna L. Karpenko is often cited by papers focused on HIV/AIDS drug development and treatment (20 papers), Biochemical and Molecular Research (14 papers) and Synthesis and Characterization of Heterocyclic Compounds (6 papers). Inna L. Karpenko collaborates with scholars based in Russia, France and United States. Inna L. Karpenko's co-authors include Alexander V. Ivanov, Marina K. Kukhanova, Sergey N. Kochetkov, Olga A. Smirnova, Anastasia L. Khandazhinskaya, Olga N. Ivanova, Л. Н. Черноусова, Olga V. Efremenkova, Т. Г. Смирнова and Alexander O. Chizhov and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Inna L. Karpenko

42 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inna L. Karpenko Russia 16 282 217 194 186 49 43 607
Guangyi Wang China 14 226 0.8× 254 1.2× 194 1.0× 134 0.7× 48 1.0× 28 629
Jie Qing China 16 256 0.9× 125 0.6× 113 0.6× 109 0.6× 101 2.1× 28 604
Dawn D. Parker United States 13 154 0.5× 203 0.9× 134 0.7× 137 0.7× 145 3.0× 22 498
Anna Garbelli Italy 15 505 1.8× 137 0.6× 59 0.3× 100 0.5× 17 0.3× 24 799
Louise Thauvette Canada 11 222 0.8× 115 0.5× 187 1.0× 65 0.3× 150 3.1× 15 549
V. L. Tunitskaya Russia 14 393 1.4× 79 0.4× 82 0.4× 54 0.3× 65 1.3× 47 530
David D. Deininger United States 9 216 0.8× 186 0.9× 107 0.6× 88 0.5× 44 0.9× 14 417
Martin DiGrandi United States 8 134 0.5× 38 0.2× 147 0.8× 143 0.8× 30 0.6× 9 406
Dominik Verdier-Pinard United States 5 117 0.4× 145 0.7× 61 0.3× 85 0.5× 17 0.3× 6 863
Yen‐Chun Lee Taiwan 11 163 0.6× 136 0.6× 98 0.5× 247 1.3× 22 0.4× 18 589

Countries citing papers authored by Inna L. Karpenko

Since Specialization
Citations

This map shows the geographic impact of Inna L. Karpenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inna L. Karpenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inna L. Karpenko more than expected).

Fields of papers citing papers by Inna L. Karpenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inna L. Karpenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inna L. Karpenko. The network helps show where Inna L. Karpenko may publish in the future.

Co-authorship network of co-authors of Inna L. Karpenko

This figure shows the co-authorship network connecting the top 25 collaborators of Inna L. Karpenko. A scholar is included among the top collaborators of Inna L. Karpenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inna L. Karpenko. Inna L. Karpenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paramonov, Alexander S., В. Л. Андронова, Inna L. Karpenko, et al.. (2025). New Benzimidazole 3′-Deoxynucleosides: Synthesis and Antiherpes Virus Properties. Biomolecules. 15(7). 922–922. 1 indexed citations
2.
Khomich, Olga A., Olga A. Smirnova, Jennifer Molle, et al.. (2024). Hepatitis C Virus Dysregulates Polyamine and Proline Metabolism and Perturbs the Urea Cycle. Cells. 13(12). 1036–1036. 1 indexed citations
3.
Ivanova, Olga N., Inna L. Karpenko, Vladimir T. Valuev-Elliston, et al.. (2024). Polyamine Catabolism Revisited: Acetylpolyamine Oxidase Plays a Minor Role due to Low Expression. Cells. 13(13). 1134–1134. 4 indexed citations
4.
Jasko, Maxim V., Inna L. Karpenko, Olga V. Efremenkova, et al.. (2024). New Biocides Based on N4-Alkylcytidines: Effects on Microorganisms and Application for the Protection of Cultural Heritage Objects of Painting. International Journal of Molecular Sciences. 25(5). 3053–3053. 2 indexed citations
5.
Jasko, Maxim V., Pavel N. Solyev, Inna L. Karpenko, et al.. (2022). 3′-Amino modifications enhance the antifungal properties of N4-alkyl-5-methylcytidines for potential biocides. New Journal of Chemistry. 46(12). 5614–5626. 7 indexed citations
6.
Karpenko, Inna L., Vladimir T. Valuev-Elliston, Olga N. Ivanova, Olga A. Smirnova, & Alexander V. Ivanov. (2021). Peroxiredoxins—The Underrated Actors during Virus-Induced Oxidative Stress. Antioxidants. 10(6). 977–977. 22 indexed citations
7.
Ivanova, Olga N., et al.. (2021). The immune response to the novel coronavirus infection. SHILAP Revista de lepidopterología. 12(1). 33–40. 2 indexed citations
8.
Jasko, Maxim V., et al.. (2021). Glycol and Phosphate Depot Forms of 4- and/or 5-Modified Nucleosides Exhibiting Antibacterial Activity. Molecular Biology. 55(1). 143–153. 4 indexed citations
9.
Jasko, Maxim V., Pavel N. Solyev, Inna L. Karpenko, et al.. (2021). Discovery of novel N4-alkylcytidines as promising antimicrobial agents. European Journal of Medicinal Chemistry. 215. 113212–113212. 10 indexed citations
10.
Jasko, Maxim V., et al.. (2020). Synthesis of water-soluble prodrugs of 5-modified 2ʹ-deoxyuridines and their antibacterial activity. The Journal of Antibiotics. 73(4). 236–246. 15 indexed citations
11.
Karpenko, Inna L., et al.. (2015). Synthesis and antimicrobial properties of 5,5′-modified 2′,5′-dideoxyuridines. Heterocyclic Communications. 21(5). 297–301.
12.
Ivanov, Alexander V., Olga A. Smirnova, Irina Yu. Petrushanko, et al.. (2015). HCV Core Protein Uses Multiple Mechanisms to Induce Oxidative Stress in Human Hepatoma Huh7 Cells. Viruses. 7(6). 2745–2770. 69 indexed citations
13.
Matyugina, Elena S., Anastasia L. Khandazhinskaya, Л. Н. Черноусова, et al.. (2012). The synthesis and antituberculosis activity of 5′-nor carbocyclic uracil derivatives. Bioorganic & Medicinal Chemistry. 20(22). 6680–6686. 48 indexed citations
14.
Solyev, Pavel N., et al.. (2012). Synthesis and Anti‐HIV Properties of New Carbamate Prodrugs of AZT. Chemical Biology & Drug Design. 80(6). 947–952. 15 indexed citations
15.
Khandazhinskaya, Anastasia L., et al.. (2011). 5′‐Phosphonate Derivatives of 2′,3′‐Dideoxy‐3′‐Thiacytidine as New Anti‐HIV Prodrugs. Chemical Biology & Drug Design. 78(1). 50–56. 5 indexed citations
16.
17.
Alexandrova, L. А., et al.. (2002). 4'-Thio-5-ethyl-2'-deoxyuridine 5'-phosphonates: Synthesis and antiviral properties. 295–298. 1 indexed citations
18.
Андронова, В. Л., et al.. (2002). 4"-Thio-5-Ethyl-2"-Deoxyuridine 5"-Phosphonates: Synthesis and Antiviral Activity. Russian Journal of Bioorganic Chemistry. 28(5). 412–418. 2 indexed citations
19.
Pokrovsky, Аndrey G., et al.. (2001). ANTI-HIV ACTIVITY OF NOVEL PHOSPHONATE DERIVATIVES OF AZT, d4T, AND ddA. Nucleosides Nucleotides & Nucleic Acids. 20(4-7). 767–769. 17 indexed citations
20.
Khandazhinskaya, Anastasia L., et al.. (2000). P-(Alkyl)-Nucleoside 5′-Hydrogenphosphonates as Depot Forms of Antiviral Nucleotide Analogues. Nucleosides Nucleotides & Nucleic Acids. 19(10-12). 1795–1804. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guangyi Wang Breakdown of academic impact, for papers by Jie Qing Breakdown of academic impact, for papers by Dawn D. Parker Breakdown of academic impact, for papers by Anna Garbelli Breakdown of academic impact, for papers by Louise Thauvette Breakdown of academic impact, for papers by V. L. Tunitskaya Breakdown of academic impact, for papers by David D. Deininger Breakdown of academic impact, for papers by Martin DiGrandi Breakdown of academic impact, for papers by Dominik Verdier-Pinard Breakdown of academic impact, for papers by Yen‐Chun Lee
Rankless by CCL
2026